Abstract:Background: China launched the Belt and Road Initiative (BRI) aiming to develop a mutually-beneficial, sustainable trade model with partner countries. The processes of international health exchanges are key parts of how this model can be sustained into the future. This paper aims to contribute to broader understanding by exploring various intentions, needs, advantages and barriers of BRI countries and then define ways China can achieve better health cooperation. Methods: In this study, a survey questionnaire was developed to investigate the perspectives of 60 international experts from 29 BRI countries. The survey was distributed and collected during the "Belt and Road High-level Meeting for Health Cooperation", held in Beijing in August 2017. The data were entered into EpiData 3.0 by two team members respectively and analyzed with SPSS22.0. Results: Altogether 58 valid questionnaires were obtained. More than 93% of participants showed their willingness to be part of BRI health cooperation. Frist, three key areas were identified, which are broadly defined as BRI country "needs": (1) "Develop health industries"; (2) "Prevent and control infectious diseases"; and (3) "Provide health services". Second, three "advantages" of participating in BRI Health Cooperation were found: (1) "The establishment of a long-term partnership"; (2) "Quality investment and financing system"; and (3) "The convenience of cooperation". Third, two main cross-cultural "barriers" for cooperation were encountered: (1) "Cultural differences"; and (2) "Lack of communication platforms". Conclusion: In this study, we have identified priority fields that China can collaborate with BRI countries and show its leadership. It is suggested that successful health cooperation between China and other BRI countries should focus on maximizing present health-industry partnerships, investment and financing, as well as overcoming cultural and communication barriers.

The Application of Mask Diplomacy: China’s Belt and Road Initiative as Health Diplomacy in Middle East and North Africa (MENA) Countries During COVID-19

China’s Health Silk Road in the Middle East and North Africa amidst COVID-19 and a Contested World Order

China’s COVID-19 Vaccine Cooperation with Southeast Asia: A Boost for the Health Silk Road Initiative

The Mask Diplomacy of China in Southeast Asia

CHINA'S NEW PUBLIC DIPLOMACY IMPLEMENTATION USING VACCINES IN THE COVID-19 PANDEMIC ERA

The political economy of vaccine distribution and China's Belt and Road Initiative

China's Silk Road and global health.

The intentions, needs, advantages and barriers: a survey of twenty-nine countries participating in the "Belt and Road Initiative" health cooperation

China’s Belt and Road Initiative with ASEAN Countries: Examining the Trade Cooperation and Impact of Coronavirus

Covid and China's BRI in Iraq and Syria

Mask Diplomacy? Understanding China's Goals in Delivering Medical Aid in the First Wave of the COVID-19 Pandemic

International Cooperation for the Belt and Road Initiative: Key Issues and Future Prospects

Belt and road initiative and healthy silk road: an alternative path for Pacific island countries to participate in global public health governance

China’s public health diplomacy in the post Covid-19 era

CHINA’S BELT AND ROAD INITIATIVE PROGRESS TOWARDS MALAYSIA’S DEVELOPMENT

Reflections on the Belt and Road Initiative

China Digital Silk Road And Indonesia Digital Transformation

The Impact of COVID-19 on the Strategic Belt and Road Initiative in the Light of Cultural Convergences and Divergences between Egypt and China: A Systematic Review

Vaccine diplomacy: nation branding and China’s COVID-19 soft power play

Mask Crisis During the COVID-19 Outbreak

Chinese Vaccine Diplomacy in the Eastern Mediterranean: Continuities and Rupture in Beijing’s Soft Power Prospects